LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,068,368,938 | -9.2% | 15,905,448 | -6.7% | 0.09% | -7.1% |
Q2 2023 | $1,176,650,727 | -25.6% | 17,045,498 | -48.0% | 0.10% | +37.5% |
Q1 2023 | $1,581,102,650 | +109.2% | 32,789,354 | +116.6% | 0.07% | -4.0% |
Q4 2022 | $755,867,574 | +47.3% | 15,141,578 | +20.4% | 0.08% | +38.9% |
Q3 2022 | $513,183,000 | +40.0% | 12,578,033 | +88.8% | 0.05% | +45.9% |
Q2 2022 | $366,505,000 | +315.9% | 6,663,704 | +174.8% | 0.04% | +428.6% |
Q1 2022 | $88,113,000 | +133.0% | 2,424,663 | +198.8% | 0.01% | +133.3% |
Q4 2021 | $37,824,000 | +16.5% | 811,508 | +26.4% | 0.00% | 0.0% |
Q3 2021 | $32,470,000 | +2037.6% | 642,200 | +1636.0% | 0.00% | – |
Q2 2021 | $1,519,000 | +41.4% | 36,994 | 0.0% | 0.00% | – |
Q1 2021 | $1,074,000 | +558.9% | 36,994 | +538.4% | 0.00% | – |
Q4 2020 | $163,000 | -98.1% | 5,795 | -98.0% | 0.00% | -100.0% |
Q3 2020 | $8,733,000 | -37.5% | 282,896 | -13.8% | 0.00% | -50.0% |
Q2 2020 | $13,965,000 | – | 328,103 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |